SSG Advises Navidea BioPharmaceuticals in the Sale of Substantially All Assets to Cardinal Health
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Navidea Biopharmaceuticals, Inc. (“Navidea” or the “Company”) in the sale of substantially all assets to Cardinal Health, Inc. (“Cardinal Health”). The sale was effectuated through a Chapter 11….
READ MORESSG Advises US Magnesium in the Sale of Select Unencumbered Assets to the Utah Division of Forestry, Fire, and State Lands
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to US Magnesium LLC (“US Magnesium” or the “Company”) in the sale of select unencumbered assets to the Utah Division of Forestry, Fire, and State Lands (“FFSL”). The sale….
READ MORESSG Advises Partners Pharmacy in the Sale of Substantially All Assets to CS One
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Partners Pharmacy Services, LLC and certain affiliates (“Partners Pharmacy” or the “Company”) in the sale of substantially all assets to CS One, LLC (“CS One”). The sale was….
READ MORESSG Capital Advisor’s 2025 Year in Review
As SSG Capital Advisors launches into our 25th anniversary year, we look back on the past year, defined by accomplishments and collaboration. In 2025, we advised clients at critical moments in their business lifecycle and delivered outcomes that matter:….
READ MORESSG Expands Debt Facility for Revere Copper Products
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Revere Copper Products, Inc. (“Revere” or the “Company”) in the expansion of its asset-based credit facility from $150 million to $207.5 million. The upsized credit facility was led….
READ MORE